BE0033-1-5MG
| InVivoMAb anti-mouse OX40L (CD134L)
| 5 mg
| BioXCell
| in vivo blocking of OX40/OX40L signaling, in vitro
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
BE0004-1-1MG
| InVivoMAb anti-mouse CD8?
| 1 mg
| BioXCell
| in vivo CD8+ T cell depletion, Immunofluorescence,
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
BE0029-5MG
| InVivoMAb anti-mouse IFN?R (CD119)
| 5 mg
| BioXCell
| in vivo IFN?R neutralization, in vitro IFN?R neutr
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
BE0004-1-25MG
| InVivoMAb anti-mouse CD8?
| 25 mg
| BioXCell
| in vivo CD8+ T cell depletion, Immunofluorescence,
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
BE0027-5MG
| InVivoMAb anti-mouse CD106 (VCAM-1)
| 5 mg
| BioXCell
| in vivo VCAM-1 neutralization, Immunofluorescence
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
BE0028-5MG
| InVivoMAb anti-mouse ICOSL (CD275)
| 5 mg
| BioXCell
| in vivo ICOSL neutralization
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
BE0055-25MG
| InVivoMAb anti-mouse IFN?
| 25 mg
| BioXCell
| in vivo IFN? neutralization, in vitro IFN? neutral
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
BE0075-1-50MG
| InVivoMAb anti-mouse Ly6G
| 50 mg
| BioXCell
| in vivo neutrophil depletion, in vivo MDSC depleti
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
BE0004-1-100MG
| InVivoMAb anti-mouse CD8?
| 100 mg
| BioXCell
| in vivo CD8+ T cell depletion, Immunofluorescence,
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
BE0042-100MG
| InVivoMAb anti-mouse IL-2
| 100 mg
| BioXCell
| in vivo IL-2 neutralization, in vitro IL-2 neutral
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
BE0001-1-50MG
| InVivoMAb anti-mouse CD3?
| 50 mg
| BioXCell
| in vivo T cell depletion, in vitro T cell stimulat
|
| Armenian Hamster
| Mouse
| Solicitar Precio
| Solicitar
|
BE0031-5MG
| InVivoMAb anti-mouse OX40 (CD134)
| 5 mg
| BioXCell
| in vivo OX40 activation, in vitro OX40 activation,
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
BE0003-3-100MG
| InVivoMAb anti-mouse CD4
| 100 mg
| BioXCell
| in vivo blockade of CD4+ T-cell responses, Western
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
BE0009-50MG
| InVivoMAb anti-mouse CD18
| 50 mg
| BioXCell
| in vivo LFA-1 neutralization
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
BE0020-1-1MG
| InVivoMAb anti-mouse CD54 (ICAM-1)
| 1 mg
| BioXCell
| in vivo ICAM-1 neutralization, Immunohistochemistr
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
BE0019-25MG
| InVivoMAb anti-mouse CD45RB
| 25 mg
| BioXCell
| in vivo anti-CD45RB_mediated tolerance induction,
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
BE0051-50MG
| InVivoMAb anti-mouse IL-12 p40
| 50 mg
| BioXCell
| in vivo IL-12p40 neutralization, p40 affinity chro
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
BE0061-5MG
| InVivoMAb anti-mouse CD8?
| 5 mg
| BioXCell
| in vivo CD8+ T cell depletion, Western blot
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
BE0086-1MG
| InVivoMAb mouse IgG2b isotype control, unknown specificity
| 1 mg
| BioXCell
|
|
| Mouse
|
| Solicitar Precio
| Solicitar
|
BE0069-50MG
| InVivoMAb anti-mouse 2C TCR
| 50 mg
| BioXCell
| Immunofluorescence, Flow cytometry
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
BE0024-5MG
| InVivoMAb anti-mouse CD80 (B7-1)
| 5 mg
| BioXCell
| in vivo CD80 blockade, Flow cytometry
|
| Armenian Hamster
| Mouse
| Solicitar Precio
| Solicitar
|
BE0072-25MG
| InVivoMAb anti-mouse T15 VH and T15 VL regions of IgM
| 25 mg
| BioXCell
| ELISA
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
BE0035-1MG
| InVivoMAb anti-mouse MAdCAM-1
| 1 mg
| BioXCell
| in vivo MAdCAM-1 neutralization, Immunofluorescenc
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
BE0083-25MG
| InVivoMAb mouse IgG1 isotype control, unknown specificity
| 25 mg
| BioXCell
|
|
| Mouse
|
| Solicitar Precio
| Solicitar
|
BE0011-50MG
| InVivoMAb anti-mouse CD22
| 50 mg
| BioXCell
| in vivo B cell depletion in combination with anti-
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
BE0077-5MG
| InVivoMAb anti-mouse MHC Class I (H-2)
| 5 mg
| BioXCell
| ex vivo blocking of MHC I-dependent interactions,
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
BE0003-2-25MG
| InVivoMAb anti-human CD4
| 25 mg
| BioXCell
| in vitro T cell stimulation/activation, in vivo CD
|
| Mouse
| Human
| Solicitar Precio
| Solicitar
|
BE0017-1-1MG
| InVivoMAb anti-mouse CD40L (CD154)
| 1 mg
| BioXCell
| in vivo blocking of CD40/CD40L signaling, in vitro
|
| Armenian Hamster
| Mouse
| Solicitar Precio
| Solicitar
|
BE0001-2-25MG
| InVivoMAb anti-human CD3
| 25 mg
| BioXCell
| in vitro T cell stimulation/activation, in vivo T
|
| Mouse
| Human
| Solicitar Precio
| Solicitar
|
BE0054-25MG
| InVivoMAb anti-mouse IFN?
| 25 mg
| BioXCell
| in vivo IFN? neutralization, in vitro IFN? neutral
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
BE0049-1MG
| InVivoMAb anti-mouse IL-10
| 1 mg
| BioXCell
| in vivo IL-10 neutralization, in vitro IL-10 neutr
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
BE0035-100MG
| InVivoMAb anti-mouse MAdCAM-1
| 100 mg
| BioXCell
| in vivo MAdCAM-1 neutralization, Immunofluorescenc
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
BE0020-2-25MG
| InVivoMAb anti-human CD54 (ICAM-1)
| 25 mg
| BioXCell
| in vitro T cell stimulation/activation, Immunofluo
|
| Mouse
| Human
| Solicitar Precio
| Solicitar
|
BE0039-25MG
| InVivoMAb anti-mouse/human CD44
| 25 mg
| BioXCell
| in vivo CD44 neutralization, in vitro CD44 neutral
|
| Rat
| Human, Mouse
| Solicitar Precio
| Solicitar
|
BE0040-50MG
| InVivoMAb anti-rat CD28
| 50 mg
| BioXCell
| in vitro T cell stimulation/activation, Flow cytom
|
| Mouse
| Rat
| Solicitar Precio
| Solicitar
|
BE0001-1-25MG
| InVivoMAb anti-mouse CD3?
| 25 mg
| BioXCell
| in vivo T cell depletion, in vitro T cell stimulat
|
| Armenian Hamster
| Mouse
| Solicitar Precio
| Solicitar
|
BE0043-50MG
| InVivoMAb anti-mouse IL-2
| 50 mg
| BioXCell
| in vivo IL-2 neutralization, in vivo IL-2 receptor
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
BE0004-2-100MG
| InVivoMAb anti-human CD8?
| 100 mg
| BioXCell
| in vivo CD8+ T cell depletion in humanized mice
|
| Mouse
| Human
| Solicitar Precio
| Solicitar
|
BE0019-50MG
| InVivoMAb anti-mouse CD45RB
| 50 mg
| BioXCell
| in vivo anti-CD45RB_mediated tolerance induction,
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
BE0046-5MG
| InVivoMAb anti-mouse IL-6
| 5 mg
| BioXCell
| in vivo IL-6 neutralization, in vitro IL-6 neutral
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
BE0020-2-5MG
| InVivoMAb anti-human CD54 (ICAM-1)
| 5 mg
| BioXCell
| in vitro T cell stimulation/activation, Immunofluo
|
| Mouse
| Human
| Solicitar Precio
| Solicitar
|
BE0086-25MG
| InVivoMAb mouse IgG2b isotype control, unknown specificity
| 25 mg
| BioXCell
|
|
| Mouse
|
| Solicitar Precio
| Solicitar
|
BE0003-2-50MG
| InVivoMAb anti-human CD4
| 50 mg
| BioXCell
| in vitro T cell stimulation/activation, in vivo CD
|
| Mouse
| Human
| Solicitar Precio
| Solicitar
|
BE0066-5MG
| InVivoMAb anti-mouse Thy1.2 (CD90.2)
| 5 mg
| BioXCell
| in vivo ILC depletion, in vivo T cell depletion, W
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
BE0060-5MG
| InVivoMAb anti-mouse VEGFR-2
| 5 mg
| BioXCell
| in vivo blocking of VEGF/VEGFR-2 signaling, in vit
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
BE0043-1-1MG
| InVivoMAb anti-mouse IL-2
| 1 mg
| BioXCell
| in vivo IL-2 neutralization, in vivo IL-2 receptor
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
BE0062-5MG
| InVivoMAb anti-mouse/human Integrin ?7
| 5 mg
| BioXCell
| in vivo blocking of integrin ?7, Immunoprecipitati
|
| Rat
| Human, Mouse
| Solicitar Precio
| Solicitar
|
BE0045-1MG
| InVivoMAb anti-mouse IL-4
| 1 mg
| BioXCell
| in vivo IL-4 neutralization, in vitro IL-4 neutral
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
BE0005-1-1MG
| InVivoMAb anti-mouse LFA-1? (CD11a)
| 1 mg
| BioXCell
| in vivo LFA-1 neutralization
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
BE0019-1-25MG
| InVivoMAb anti-human CD47
| 25 mg
| BioXCell
| in vitro CD47 neutralization, in vivo CD47 neutral
|
| Mouse
| Human
| Solicitar Precio
| Solicitar
|